1. Allessie MA, Rensma PL, Brugada J, Smeets JLRM, Penn O, Kirchhof CJHJ (1990) Pathophysiology of Atrial Fibrillation. In: Zipes D, Jalife J (eds) Cardiac Electrophysiology. From Cell to Bedside. Saunders, London
2. Antoni H (1971) Electrophysiological Mechanisms Underlying Pharmacological Models of Cardiac Fibrillation. Naunyn-Schmiedebergs Archiv of Pharmacology 269: 177–199
3. Jackman WM, Friday KJ, Anderson JL, Aliot EM, Clark M (1988) The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Progress in cardiovascular diseases 31: 115–172
4. Ranger S, Talajic M, Lemery R, Roy D, Nattel S (1989) Amplification of flecainide-induced ventricular conduction slowing by exercise. A potentially significant clinical consequence of use-dependent sodium-channel blockade. Circulation 79: 1000–1006
5. Weirich J, Antoni H (1986) Vulnerability of the Heart to Ventricular Fibrillation: Basic Mechanisms. In: Rupp H (ed) The Regulation of Heart Function. Thieme, New York